Artiva Biotherapeutics, Inc. (ARTV)
About Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $0
- Net income
- -$83.9M
- Total assets
- $130.9M
- Market cap
- $332.8M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $89.8M
- Operating income
- -$89.8M
- Income tax
- $0
- Net income
- -$83.9M
- EPS (basic)
- $-3.43
- EPS (diluted)
- $-3.43
Balance sheet
- Total assets
- $130.9M
- Current assets
- $112.7M
- Total liabilities
- $21.0M
- Current liabilities
- $13.1M
- Shareholders’ equity
- $110.0M
Cash flow
- Operating cash flow
- -$76.8M
- Investing cash flow
- $63.4M
- Financing cash flow
- $9.0K
- Net cash flow
- -$13.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $332.8M
- EPS (diluted)
- $-3.43
- Shares outstanding
- 33.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 19, 2024
Artiva Biotherapeutics, Inc. (ARTV) Stock Price
- Reported a net loss of $83.9M in FY2025.
- Trading 25% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Artiva Biotherapeutics, Inc..
Write a review
News about Artiva Biotherapeutics, Inc.
News & sentiment via Polygon.io
Artiva Biotherapeutics, Inc.: frequently asked questions
Is Artiva Biotherapeutics, Inc. an American company?
Artiva Biotherapeutics, Inc. is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Artiva Biotherapeutics, Inc. headquartered?
Artiva Biotherapeutics, Inc. is headquartered in San Diego, California, United States.
Is Artiva Biotherapeutics, Inc. publicly traded?
Yes — Artiva Biotherapeutics, Inc. is a publicly traded company. Its stock trades under the ticker symbol ARTV on the NASDAQ.
What does Artiva Biotherapeutics, Inc. do?
Artiva Biotherapeutics, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
